Key result
The development of vaccines against African swine fever virus is hindered by the virus's complex structure, lack of continuous cell lines, and risk of reversion to virulence.
Why the study?
African swine fever virus is spreading globally and vaccines are currently unavailable, creating an urgent need to address the obstacles in designing an effective and safe vaccine.
Despite significant obstacles such as the virus's complex structure and lack of suitable cell lines, the development of a safe and effective vaccine against African swine fever virus remains a critical and achievable goal.
No takes yet. Share an insight, caveat, or question.
Highlights significant barriers to a safe ASFV vaccine; leaves open the path to viability until.
Turlewicz‐Podbielska et al. (2021) conducted a review in African swine fever virus (ASFV). ASFV vaccines was evaluated. The development of vaccines against African swine fever virus is hindered by the virus's complex structure, lack of continuous cell lines, and risk of reversion to virulence.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: